SARC-F联合FRAX预筛对老年社区人群髋部骨折预防的增益价值
前瞻性队列纳入2000名男性及2000名女性≥65岁中国社区成人,随访约10年。SARC-F对FRAX髋部骨折风险预测有独立价值,男性调整HR 1.24(95%CI 1.02,1.52),女性1.15(0.99,1.13)。SARC-F联合FRAX较单用FRAX提高预测敏感性,男性从58.7%升至76.2%,女性从69.6%升至78.3%,ROC曲线下面积保持0.67不降。
要点
- SARC-F与FRAX联合预筛可提高老年髋部骨折预测敏感性,男性提升更明显。
- 联合预筛可节省超过半数DXA评估,优于无预筛策略。
- SARC-F对髋部骨折风险有独立预测价值,男性调整HR 1.24(1.02,1.52)。
核心结论
- SARC-F与髋部骨折风险轻度增加相关,在男性中尤为明显。
- 在FRAX基础上联合肌少症评估有助于识别髋部骨折高风险老年人,以进行更密集筛查和/或预防干预。
研究设计与样本
- 前瞻性队列研究,纳入2000名中国男性和2000名中国女性,年龄≥65岁,来自当地社区,前瞻性随访约10年。
- 基线采用DXA测量髋部和腰椎面积骨密度,并计算10年FRAX髋部骨折概率及改良SARC-F评分。
主要发现
- 随访期间,男性63例(3.2%)、女性69例(3.5%)发生至少1次髋部骨折。
- SARC-F对FRAX髋部骨折风险预测具有独立价值,男性调整HR 1.24(95%CI 1.02,1.52),女性1.15(95%CI 0.99,1.13)。
- 与单用FRAX相比,SARC-F联合FRAX使预测敏感性在男性从58.7%升至76.2%,女性从69.6%升至78.3%,ROC曲线下面积保持0.67不降。
- FRAX联合SARC-F预筛较无预筛可节省超过半数DXA评估。
关键数值与推荐
- SARC-F为简易5项问卷,用于肌少症筛查。
- FRAX为骨折风险评估工具,计算10年髋部骨折概率。
- 联合预筛策略可提高敏感性并减少DXA评估需求。
临床怎么用
- 在社区老年髋部骨折预筛中,可考虑在FRAX基础上联合SARC-F识别高风险个体。
- 联合预筛有助于更高效地选择需DXA评估和预防干预的老年人。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the potential added value of a simple 5-item questionnaire for sarcopenia screening (SARC-F) to the Fracture Risk Assessment Tool (FRAX) for hip fracture risk prediction, in order to identify at-risk older adults for screening with dual-energy x-ray absorptiometry (DXA). DESIGN: A prospective cohort study. SETTING AND PARTICIPANTS: Two thousand Chinese men and 2000 Chinese women aged 65 years or older were recruited from local communities and were prospectively followed up for about 10 years. MEASURES: Areal bone mineral density (BMD) of hip and lumbar spine were measured by DXA at baseline. Ten-year FRAX probability of hip fracture was calculated using the baseline risk factors. Information from the baseline questionnaire was extracted to calculate a modified SARC-F score. The independent predictive values of SARC-F and FRAX questionnaire were evaluated using multivariate survival analysis. The added predictive values of SARC-F to FRAX for pre-DXA screening were examined. RESULTS: During the follow-up, 63 (3.2%) men and 69 (3.5%) women had at least 1 incident hip fracture. SARC-F had an independent value of FRAX for hip fracture risk prediction, with an adjusted hazard ratio [95% confidence interval (CI)] of 1.24 (1.02, 1.52) and 1.15 (0.99, 1.13) in men and women, respectively. Compared with using FRAX, using SARC-F in conjunction with FRAX made the sensitivity for prediction rise from 58.7% to 76.2% in men and from 69.6% to 78.3% in women, with a nondecreased area under receiver operating characteristic curve of 0.67. Prescreening using FRAX in conjunction with SARC-F could save more than half of the DXA assessment than with no prescreening. CONCLUSIONS/IMPLICATIONS: SARC-F is associated with a modest increase in hip fracture risk, especially in men. Conjoint evaluation for sarcopenia in addition to FRAX screening may help identify older adults at higher risk of hip fracture for more intensive screening and/or preventive interventions.
引用
- Su Y, Woo JW, Kwok TCY, et al. The Added Value of SARC-F to Prescreening Using FRAX for Hip Fracture Prevention in Older Community Adults. J Am Med Dir Assoc. 2018. PMID: 30314676. doi:10.1016/j.jamda.2018.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。